Dr Will Malone, a US-based endocrinologist, posted a twitter thread on "Rapid Onset Gender Dysphoria" (ROGD) in early December. The thread was highly informative. We have compiled and edited this thread into blogpost format.
The UK High Court has ruled that puberty blockers are experimental, are not "fully reversible", and lack evidence of benefit. The ruling confirms Professor Heneghan's view of puberty suppression as an “unregulated live experiment on children”, and signals the "beginning of the end" of a disturbing chapter in medical history in the UK. It is now only a matter of time before authorities halt the same unregulated experiment on New Zealand children.
Gonadotrophin-releasing hormone agonists (GnRHa) chemically castrate recipients and suppress puberty in adolescents. Clinicians in New Zealand use GnRHa to treat gender dysphoria in adolescents.
Fully Informed documents the poor quality of research that supports this practice. We encounter several broader issues that come up when looking into the GnRHa research. This article summarises some of these issues:
- The connection with eating disorders and autism.
- The use of GnRHa as a pause button.
- Psychotherapy as an alternative treatment.
- Recent medical policy and research reversals.
The number of adolescents, particularly girls, presenting with gender dysphoria has risen exponentially in NZ and other countries since around 2010. Treating gender dysphoric adolescents with puberty blockers has become a "freely" available treatment option in New Zealand.